Suppr超能文献

2021 年恶心和呕吐:全面更新。

Nausea and Vomiting in 2021: A Comprehensive Update.

机构信息

Department of Medicine, University of Louisville.

Department of Medicine, Division of Gastroenterology, Hepatology & Nutrition, University of Louisville.

出版信息

J Clin Gastroenterol. 2021 Apr 1;55(4):279-299. doi: 10.1097/MCG.0000000000001485.

Abstract

GOAL

A comprehensive review of treatments for nausea and vomiting (N/V).

BACKGROUND

N/V are common symptoms encountered in medicine. While most cases of acute N/V related to a specific cause can be straightforward to manage, other cases of acute N/V such as chemotherapy-induced N/V and especially chronic unexplained N/V can be difficult to control, leading to a significant decline in the patient's quality of life and increased cost of medical care from repeated hospitalizations.

STUDY

Traditional management has relied on pharmacotherapy which may be inadequate in a certain proportion of these patients. Many of the medications used in the management of N/V have significant side effect profiles making the need for new and improved interventions of great importance.

RESULTS

This review covers a broad review of the pathophysiology of N/V, pharmacotherapy, including safety concerns and controversies with established pharmaceuticals, newer immunotherapies, bioelectrical neuromodulation (including gastric electrical stimulation), behavioral and surgical therapies, and complementary medicine.

CONCLUSION

On the basis of emerging understandings of the pathophysiology of N/V, improved therapies are becoming available.

摘要

目的

全面综述恶心和呕吐(N/V)的治疗方法。

背景

N/V 是医学中常见的症状。虽然大多数与特定病因相关的急性 N/V 病例的治疗较为简单,但其他类型的急性 N/V,如化疗引起的 N/V,尤其是慢性不明原因的 N/V,可能难以控制,导致患者的生活质量显著下降,并因反复住院而增加医疗费用。

研究

传统的治疗方法依赖于药物治疗,但在某些患者中可能不够有效。在管理 N/V 中使用的许多药物都有明显的副作用,因此,非常需要新的和改进的干预措施。

结果

本综述涵盖了对 N/V 的病理生理学、药物治疗的广泛综述,包括与已上市药物相关的安全性问题和争议、新型免疫疗法、生物电神经调节(包括胃电刺激)、行为和手术治疗以及补充医学。

结论

基于对 N/V 病理生理学的新认识,越来越多的改善治疗方法正在出现。

相似文献

1
Nausea and Vomiting in 2021: A Comprehensive Update.
J Clin Gastroenterol. 2021 Apr 1;55(4):279-299. doi: 10.1097/MCG.0000000000001485.
3
Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting.
Cochrane Database Syst Rev. 2006 Apr 19(2):CD002285. doi: 10.1002/14651858.CD002285.pub2.
4
Effectively managing chemotherapy-induced nausea and vomiting.
Br J Nurs. 2011;20(17):S7-8, S10-2, S14-15. doi: 10.12968/bjon.2011.20.Sup10.S7.
5
The effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: a randomized controlled trial.
J Pain Symptom Manage. 2014 Jan;47(1):12-25. doi: 10.1016/j.jpainsymman.2013.03.007. Epub 2013 Apr 17.
6
Management of chemotherapy-induced nausea and vomiting.
Indian Pediatr. 2010 Feb;47(2):149-55. doi: 10.1007/s13312-010-0023-4.
8
2016 Updated MASCC/ESMO consensus recommendations: Management of nausea and vomiting in advanced cancer.
Support Care Cancer. 2017 Jan;25(1):333-340. doi: 10.1007/s00520-016-3371-3. Epub 2016 Aug 17.
9
[Prevention and treatment of antineoplastic drug-induced nausea and vomiting in pediatric onco-hematology: An update].
Bull Cancer. 2020 Jul-Aug;107(7-8):800-812. doi: 10.1016/j.bulcan.2020.03.015. Epub 2020 May 14.
10
Activity-based cost analysis of opioid-related nausea and vomiting among inpatients.
J Opioid Manag. 2014 Nov-Dec;10(6):415-22. doi: 10.5055/jom.2014.0238.

引用本文的文献

1
Thymol as a Potential Natural Antiemetic: Insights From In Vivo and In Silico Studies.
Food Sci Nutr. 2025 Sep 10;13(9):e70832. doi: 10.1002/fsn3.70832. eCollection 2025 Sep.
3
Management of gastrointestinal adverse effects in immune-based combination therapy for advanced renal carcinoma: when the oncologist meets the gastroenterologist.
Therap Adv Gastroenterol. 2025 Aug 8;18:17562848251358174. doi: 10.1177/17562848251358174. eCollection 2025.
4
A patient with acute hepatitis E and intractable vomiting: a case report.
Front Med (Lausanne). 2025 Jul 21;12:1614921. doi: 10.3389/fmed.2025.1614921. eCollection 2025.
5
Refractory Nausea and Vomiting Due to Central Nervous System Injury: A Focused Review.
Life (Basel). 2025 Jun 27;15(7):1021. doi: 10.3390/life15071021.
9
Non-pharmacological interventions for side effects of antineoplastic chemotherapy prioritized by patients: systematic review.
Rev Cuid. 2024 Oct 11;15(3):e3612. doi: 10.15649/cuidarte.3612. eCollection 2024 Sep-Dec.
10
The Pharmacological and Clinical Roles of Antiemetics: A Narrative Review.
Cureus. 2025 Jan 13;17(1):e77370. doi: 10.7759/cureus.77370. eCollection 2025 Jan.

本文引用的文献

2
Both gastric electrical stimulation and pyloric surgery offer long-term symptom improvement in patients with gastroparesis.
Surg Endosc. 2021 Aug;35(8):4794-4804. doi: 10.1007/s00464-020-07960-3. Epub 2020 Oct 6.
3
Efficacy and Safety of Tradipitant in Patients With Diabetic and Idiopathic Gastroparesis in a Randomized, Placebo-Controlled Trial.
Gastroenterology. 2021 Jan;160(1):76-87.e4. doi: 10.1053/j.gastro.2020.07.029. Epub 2020 Jul 18.
4
Pathophysiology of Gastroparesis Syndromes Includes Anatomic and Physiologic Abnormalities.
Dig Dis Sci. 2021 Apr;66(4):1127-1141. doi: 10.1007/s10620-020-06259-6. Epub 2020 Apr 23.
5
Overall safety of relamorelin in adults with diabetic gastroparesis: Analysis of phase 2a and 2b trial data.
Aliment Pharmacol Ther. 2020 Jun;51(11):1139-1148. doi: 10.1111/apt.15711. Epub 2020 Apr 17.
6
Effects of Gastric Neuromodulation on Crohn's Disease in Patients With Coexisting Symptoms of Gastroparesis.
Neuromodulation. 2020 Dec;23(8):1196-1200. doi: 10.1111/ner.13118. Epub 2020 Feb 18.
8
What Causes Functional Gastrointestinal Disorders? A Proposed Disease Model.
Am J Gastroenterol. 2020 Jan;115(1):41-48. doi: 10.14309/ajg.0000000000000485.
10
Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial.
Gastroenterology. 2020 Feb;158(3):506-514.e2. doi: 10.1053/j.gastro.2019.10.018. Epub 2019 Oct 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验